Investment Firms in Lausanne, Switzerland
Lausanne, Switzerland's investment landscape is shaped by Biotech & Life Sciences, with 100% of its 2 investment firms focused on this sector. The most active by portfolio size are Debiopharm Innovation Fund, and HackCapital.
Biotech & Life Sciences dominates the investment landscape in Lausanne, with 100% of investment firms focused on this sector.
Last updated: 4 May 2026
Investment Firms
2
Total Investments
6
Top Sector
Biotech & Life Sciences
Top Stage
Series A
Top Investment Sectors in Lausanne
The most popular sector focus among Lausanne investment firms is Biotech & Life Sciences, with 2 investment firms (100%) investing in the space. This is followed by AI (1), Telecom (1), Healthcare (1), Food & Agriculture (1).
Investment Stages in Lausanne
Lausanne investment firms are most active at the Series A stage (1 investment firm). This is followed by Seed (1), Series C (1).
